Although there is no evidence that the risk of other cancer types in individuals with a CDH1 variant is significantly increased [8], multiple case reports have noted the occurrence of CRC and appendiceal Signet-Ring Cell Carcinomas in CDH1 variant carriers [5]. This evidence concerns the gene CDH1 and signet ring cell carcinoma.